Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clevidipine in postoperative hypertension (ESCAPE-2)
NCT00093262Phase 3Completed
- Sponsor
- The Medicines Company
- Start
- Dec 2003
- Primary completion
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of clevidipine in hypertension (HTN), sponsored by The Medicines Company. Started Dec 2003; status: completed.
02
Drugs
clevidipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00093262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00093262.